Press Releases

07.09.2024

Pfizer to Launch Process to Identify a Successor for Dr. Mikael Dolsten, Chief Scientific Officer and President, Pfizer Research & Development

04.25.2024

Pfizer Announces 2024 Shareholder Meeting Preliminary Results

04.24.2024

Pfizer Declares Second-Quarter 2024 Dividend

04.11.2024

Pfizer Invites Shareholders to Attend Virtual-Only 2024 Annual Meeting of Shareholders on April 25

01.30.2024

Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance

12.14.2023

Pfizer Completes Acquisition of Seagen

12.12.2023

Pfizer Receives All Required Regulatory Approvals to Complete the Acquisition of Seagen

10.13.2023

Pfizer Amends U.S. Government Paxlovid Supply Agreement and Updates Full-Year 2023 Guidance

05.16.2023

Pfizer Prices $31,000,000,000 Debt Offering

04.27.2023

Pfizer Announces 2023 Shareholder Meeting Preliminary Results